Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Related
Posts
Asia Pacific Situational Updates on Generic DAAs – June 2017
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Response from CEO, CHAI about the Quick Start program in November 2016
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
